Hospital News and Research

RSS

Pemetrexed/docetaxel with cisplatin achieve similar progression-free survival in NSCLC patients

The first direct comparison of treating non-squamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival, although docetaxel was associated with more frequent adverse events.

30 Sep 2014

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

The Brain & Behavior Research Foundation will honor eight scientists with its 2014 Outstanding Achievement Prizes for work delving into psychiatric disorders that affect one in four people. The awards, which celebrate the transformative power of neuroscience and psychiatric research to improve the lives of people with mental illness, will be presented at the Foundation's National Awards Dinner at the Pierre Hotel.

30 Sep 2014

UCSF gets CDC grant to provide expert guidance to clinicians who prescribe anti-HIV medications

The UCSF Clinician Consultation Center at San Francisco General Hospital and Trauma Center has been funded by the Centers for Disease Control and Prevention to provide a PrEPline, a telephone consultation service that gives expert guidance to healthcare providers across the nation who prescribe antiretroviral medications to HIV uninfected individuals to prevent HIV.

30 Sep 2014

Novel imaging technique could revolutionise diagnosis of neuroblastoma

CANCER RESEARCH UK's Centre for Drug Development, in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed.

30 Sep 2014

UC Davis research highlights need for better guidance for primary care providers

Short questionnaires used to identify patients at risk for depression are linked with antidepressant medications being prescribed when they may not be needed, according to new research from UC Davis Health System published in the September-October issue of the Journal of the American Board of Family Medicine.

30 Sep 2014

New scaling law helps predict humans' risk of blast-induced traumatic brain injury

Since the start of the military conflicts in Iraq and Afghanistan, more than 300,000 soldiers have returned to the United States with traumatic brain injury caused by exposure to bomb blasts - and in particular, exposure to improvised explosive devices, or IEDs. Symptoms of traumatic brain injury can range from the mild, such as lingering headaches and nausea, to more severe impairments in memory and cognition.

30 Sep 2014

Seven NIH research contracts awarded to identify novel adjuvant candidates

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability.

30 Sep 2014

State highlights: Calif. health insurers and contraception coverage; Alaska sues Xerox over Medicaid payment systems

Health insurance policies in California will have to cover all federally approved contraceptives for women by 2016 without charging co-payments under legislation signed this week by Gov. Jerry Brown, countering trends in other states and the U.S. Supreme Court. The bill, SB1053 by Sen. Holly Mitchell, D-Los Angeles, expands state laws that required coverage for most birth-control drugs and devices approved by the U.S. Food and Drug Administration. The new law mandates coverage for all FDA-approved contraception, prohibits co-payments and includes managed-care Medi-Cal plans, which are not expressly covered by current laws (Egelko, 9/27).

30 Sep 2014

PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.

30 Sep 2014

Pertuzumab combined with trastuzumab and chemotherapy extends lives of HER2-positive breast cancer patients

Patients with HER2-positive breast cancer that has spread to other parts of their body live around 16 months longer if treated with a combination of pertuzumab, trastuzumab and chemotherapy compared to those treated with trastuzumab and chemotherapy alone, updated results from the CLEOPATRA study reveal.

30 Sep 2014

Combination therapy achieves greater progression-free survival, response rates in melanoma

Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieves greater progression-free survival and response rates than vemurafenib plus placebo in BRAF-mutation positive melanoma, according to phase III data presented at the ESMO 2014 Congress in Madrid, Spain.

30 Sep 2014

Antibiotic exposure in infancy linked to childhood obesity

Repeated exposure to broad-spectrum antibiotics in the first two years of life is associated with early childhood obesity, say researchers from The Children's Hospital of Philadelphia in a retrospective study based on data from electronic health records from the extensive CHOP Care Network.

30 Sep 2014

Specific nurse-to-patient staffing standards lower job-related injuries, illnesses for nurses

A 2004 California law mandating specific nurse-to-patient staffing standards in acute care hospitals significantly lowered job-related injuries and illnesses for both registered nurses and licensed practical nurses, according to UC Davis research published online in the International Archives of Occupational and Environmental Health.

30 Sep 2014

Targeted treatments may improve idiopathic PAH survival

Patients with idiopathic pulmonary arterial hypertension may live longer if they are given targeted treatments than if they receive conventional management, researchers suggest.

29 Sep 2014

Weekly musculoskeletal pain on the rise among young adults

Research from Finland shows an increase in the prevalence of frequent musculoskeletal symptoms in young adults, which suggests the need for early intervention.

29 Sep 2014

Neuropsychiatric symptoms variable in early Parkinson’s disease

The prevalence of neuropsychiatric symptoms is increased in patients with early Parkinson’s disease, although many remain stable over time, shows follow-up of the Parkinson’s Progression Markers Initiative.

29 Sep 2014

Christiana Care Health System wins 2014 Health Devices Achievement Award

ECRI Institute is pleased to announce Christiana Care Health System, Wilmington, DE, as the winner of its 9th Annual Health Devices Achievement Award.

29 Sep 2014

Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

Galmed Pharmaceuticals Ltd. ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT™ devices and accessories from Itamar Medical Ltd.

29 Sep 2014

Raritan Bay Medical Center accepts customer service inquiries via Twitter

Raritan Bay Medical Center announces it will begin to accept customer service inquiries via Twitter, the social media website.

29 Sep 2014

Bigger challenges forecast for health law's second enrollment drive

Enrolling new customers will be more complicated this time around because potential enrollees may be harder to reach, reports The Wall Street Journal.

29 Sep 2014

Hospital News and Research

Pemetrexed/docetaxel with cisplatin achieve similar progression-free survival in NSCLC patients

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

UCSF gets CDC grant to provide expert guidance to clinicians who prescribe anti-HIV medications

Novel imaging technique could revolutionise diagnosis of neuroblastoma

UC Davis research highlights need for better guidance for primary care providers

New scaling law helps predict humans' risk of blast-induced traumatic brain injury

Seven NIH research contracts awarded to identify novel adjuvant candidates

State highlights: Calif. health insurers and contraception coverage; Alaska sues Xerox over Medicaid payment systems

PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma

Pertuzumab combined with trastuzumab and chemotherapy extends lives of HER2-positive breast cancer patients

Combination therapy achieves greater progression-free survival, response rates in melanoma

Antibiotic exposure in infancy linked to childhood obesity

Specific nurse-to-patient staffing standards lower job-related injuries, illnesses for nurses

Targeted treatments may improve idiopathic PAH survival

Weekly musculoskeletal pain on the rise among young adults

Neuropsychiatric symptoms variable in early Parkinson’s disease

Christiana Care Health System wins 2014 Health Devices Achievement Award

Galmed Pharmaceuticals purchases EndoPAT devices, accessories from Itamar Medical

Raritan Bay Medical Center accepts customer service inquiries via Twitter

Bigger challenges forecast for health law's second enrollment drive

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News